Gladstone Institutes Newsroom

New study shows potentiating a subset of NMDA receptors may be beneficial in Alzheimer's disease and Dravet syndrome.

Machine, Meet Stem Cells

The biotech company MedaRed, Inc. is founded on groundbreaking basic research from Gladstone Institutes, UC San Francisco, and UC San Diego

The National Institutes of Health renews its funding of a promising internship program at the Gladstone Institutes

New study challenges a fundamental assumption of how proteins interact with the human genome

Shipman will build new technologies to understand the development of the brain

Gladstone researchers have stopped the detrimental effects of blood-brain barrier leaks

Robert Wicks appointed the new vice president of philanthropy

The co-inventor of CRISPR genome editing technology expands research collaborations to San Francisco's Mission Bay research community

Scientists from the Gladstone Institutes discover how to enhance the longevity of cells that kill tumors and infected cells

A new computational approach from the Gladstone Institutes identifies genes that may help microbes live successfully in the human gut

Researchers at the Gladstone Institutes provide answers to decade-old questions

Gladstone scientists identify genes that enable adult cells to divide and multiply

Different routes of sexual transmission affect the immune system's response to a virus, shows new study.

Study will use innovative technology to focus on neurodegenerative diseases

Scientists develop a cheaper, quicker, and more reliable stem cell-based technology to facilitate drug discovery

A new study uses large-scale genetic approach to uncover human genes controlling HIV infection.

New study shows how patterns in brain activity can be an early predictor of Alzheimer's symptoms

Gladstone researchers Warner C. Greene and Eytan Herzig collaborated with Xyphos Biosciences, Inc., to develop a novel immunotherapy for HIV.

Benoit Bruneau is selected to lead the Gladstone Institute of Cardiovascular Disease

Study by Gladstone scientists finds blood protein destroys memory storage sites in the brain and may lead to new treatments

Insight into how three of the world's most devastating viruses interact with human cells opens the door for much-needed treatments

The NIH funds an initiative at the Gladstone Institutes to assess the safety of CRISPR-like therapies in human tissues

Gladstone researchers discover a noisy step in gene expression

New study from the Gladstone Institutes uncovers how the viruses bypass your body's defense mechanisms

A team of scientists from the Gladstone Institutes, UCSF, and UC Berkeley identify nearly 200 potential drug targets

Scientists at Gladstone reveal how the virus decides between fates.

New insights into how a gene causes damage could impact future drug development

Gladstone launches the new Institute of Data Science and Biotechnology

Gladstone scientists show how a type of neuron improves procedural learning.

Activating a single gene is sufficient to change skin cells into stem cells.

Study from the Gladstone Institutes may lead to new treatments for diseases like multiple sclerosis

With $4.8 million from the NIH, Gladstone scientists will investigate how the protein apoE4 causes neurodegeneration in Alzheimer's disease.

Five new members join the Gladstone Foundation Board

NIH award supports collaborative work to discover the connection between neurovascular dysfunction and cognitive decline in Alzheimer's disease.

Keller's work with pluripotent stem cells has led to a platform for disease modeling and regenerative medicine

Basic science discovery explains a fundamental way human cells differ from yeast cells.

An unexpected brain region is important for Dravet Syndrome, finds study from the Gladstone Institutes

Gladstone scientists uncover new gatekeeper function of the anti-aging molecule

New discoveries about how cells self-organize could help researchers create more authentic organ models for research or transplantation

Connecting the dots between human papillomavirus and smoking-related cancers

Scientists shed light on cells' most fundamental process

Wernig was selected for his groundbreaking research in cellular reprogramming and stem cell-based therapies for genetic disease

BioMotiv and Cure Network Dolby Acceleration Partners collaborate to advance the development of better treatments for brain disorders

Gladstone and Google AI collaborate to uncover the tip of an iceberg that could transform biomedical science

Transplanting a special type of neuron into the brain restores cognitive functions in Alzheimer's models, shows a new study by Gladstone scientists

Scientists examine the fastest changing regions in the human genome to learn how our species evolved.

New study explains what happens when the immune system ages